Dr. Rovina Ruslami is a professor of pharmacology at the Universitas Padjadjaran Bandung, Indonesia. She has led and/or contributed to over a dozen clinical trials, focusing on the improvement of TB treatment by understanding the pharmacology of TB drugs, such as using higher doses of Rifampin for TB Meningitis, TB Infection, and Pulmonary TB.
Current research projects:
- SSTaRLeT (Short and Safer Treatment Regiment for Latent TB Infection), CIHR, PI.
- PRIMe (Pharmacokinetics of antituberculosis drugs in breastfeeding women), CIHR, PI.
- M72 TB vaccine trials and HARVEST (High dose Rifampicin for TB Meningitis) PK study, MRC, UK.
Email: n.ruslami [at] gmail.com
